Literature DB >> 19639792

[Analysis of myocardial proteomic alteration after Qishenyiqi formula treatment in acute infarcted rat hearts].

Chengtao Hong1, Yi Wang, Jianzhou Lou, Qian Liu, Haibin Qu, Yiyu Cheng.   

Abstract

OBJECTIVE: Use proteomic technique to research the effects of Qishenyiqi formula in acute myocardial infarcted rats, and further explore its protein-level mechanism.
METHOD: The rat hearts of sham, myocardial infarcted and Qishenyiqi formula treated groups were collected. Analyzing and comparing the differences of protein expressions in each groups with two-dimensional electrophoresis, computer-assisted image analysis and matrix-assisted laser desorption/ionization mass spectrometry. RESULT: Compared with myocardial infarcted group, there were 14 protein expressions changed in Qishenyiqi formula treated group. The result showed that 9 protein expressions were up-regulated, and 5 ones were down-regulated significantly. These proteins are associated with energy metabolism, mitochondrial function, oxidative stress, cytoskeleton and others.
CONCLUSION: Myocardial protective effects of Qishenyiqi formula in myocardial infarcted procedure might be closely related to the recovery of energy supply, the reduction of oxidative stress, as well as the promotion of cell recovery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19639792

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  10 in total

Review 1.  Efficacy-oriented compatibility for component-based Chinese medicine.

Authors:  Jun-hua Zhang; Yan Zhu; Xiao-hui Fan; Bo-li Zhang
Journal:  Acta Pharmacol Sin       Date:  2015-04-13       Impact factor: 6.150

2.  Effects of Qishen Yiqi Dripping Pills () in Reducing Myocardial Injury and Preserving Microvascular Function in Patients Undergoing Elective Percutaneous Coronary Intervention: A Pilot Randomized Study.

Authors:  Gui-Xin He; Jun Xie; Hao Jiang; Wei Tan; Biao Xu
Journal:  Chin J Integr Med       Date:  2017-05-03       Impact factor: 1.978

3.  Drug target prediction based on the herbs components: the study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart disease.

Authors:  Yong Wang; Zhongyang Liu; Chun Li; Dong Li; Yulin Ouyang; Junda Yu; Shuzhen Guo; Fuchu He; Wei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-08       Impact factor: 2.629

4.  Identifying roles of "Jun-Chen-Zuo-Shi" component herbs of QiShenYiQi formula in treating acute myocardial ischemia by network pharmacology.

Authors:  Leihong Wu; Yi Wang; Zheng Li; Boli Zhang; Yiyu Cheng; Xiaohui Fan
Journal:  Chin Med       Date:  2014-09-16       Impact factor: 5.455

5.  Qishenyiqi protects ligation-induced left ventricular remodeling by attenuating inflammation and fibrosis via STAT3 and NF-κB signaling pathway.

Authors:  Chun Li; Yong Wang; Qi Qiu; Tianjiao Shi; Yan Wu; Jing Han; Xingyun Chai; Wei Wang
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

6.  QiShenYiQi Attenuates Renal Interstitial Fibrosis by Blocking the Activation of β-Catenin.

Authors:  Zhanmei Zhou; Zheng Hu; Mei Li; Fengxin Zhu; Hao Zhang; Jing Nie; Jun Ai
Journal:  PLoS One       Date:  2016-09-16       Impact factor: 3.240

7.  Effect of QSKL on MAPK and RhoA Pathways in a Rat Model of Heart Failure.

Authors:  Kai Xia; Qiyan Wang; Chun Li; Zifan Zeng; Yong Wang; Wei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2017-04-18       Impact factor: 2.629

8.  Ginsenoside Re Improves Isoproterenol-Induced Myocardial Fibrosis and Heart Failure in Rats.

Authors:  Quan-Wei Wang; Xiao-Feng Yu; Hua-Li Xu; Xue-Zhong Zhao; Da-Yuan Sui
Journal:  Evid Based Complement Alternat Med       Date:  2019-01-01       Impact factor: 2.629

9.  Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2.

Authors:  Yong Wang; Chun Li; Yulin Ouyang; Junda Yu; Shuzhen Guo; Zhongyang Liu; Dong Li; Jing Han; Wei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-13       Impact factor: 2.629

10.  Qi-shen-yi-qi dripping pills for the secondary prevention of myocardial infarction: a randomised clinical trial.

Authors:  Hongcai Shang; Junhua Zhang; Chen Yao; Baoyan Liu; Xiumei Gao; Ming Ren; Hongbao Cao; Guohua Dai; Weiliang Weng; Sainan Zhu; Hui Wang; Hongjuan Xu; Boli Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-14       Impact factor: 2.629

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.